Rasitrio
Active substance: aliskiren, amlodipine, hydrochlorothiazide
aliskiren, amlodipine, hydrochlorothiazide
Centralised EU authorisationWithdrawn
Marketing holder: Novartis Europharm Ltd.
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
Registration
- Registration number
- EMEA/H/C/002017
- Registration status
- Withdrawn
- ATC code
- C09XA54
Sources
- product · EMA · EMEA/H/C/002017 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002017 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002017 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/002017 · Verified 2026-10-09
- ingredients.2 · EMA · EMEA/H/C/002017 · Verified 2026-10-09